Compare CADL & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | MIR |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 4.6B |
| IPO Year | 2021 | N/A |
| Metric | CADL | MIR |
|---|---|---|
| Price | $5.04 | $18.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | $19.00 | ★ $27.25 |
| AVG Volume (30 Days) | 1.2M | ★ 3.4M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | $24.16 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ N/A | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.25 | $12.00 |
| 52 Week High | $7.24 | $30.28 |
| Indicator | CADL | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 44.54 |
| Support Level | $4.58 | N/A |
| Resistance Level | $5.42 | $22.23 |
| Average True Range (ATR) | 0.25 | 1.02 |
| MACD | 0.03 | 0.09 |
| Stochastic Oscillator | 70.00 | 65.73 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.